Oncology Nutrition Market

Oncology Nutrition Market Analysis (2023 to 2033)

The oncology nutrition market size is projected to be valued at USD 2.07 billion in 2023 and is expected to be valued at USD 4.87 billion by 2033. The demand for oncology nutrition is likely to record an average CAGR of 8.9% during the forecast period.

Medical nutrition therapy for cancer is crucial for enhancing physical capacity, coping with cancer therapies, and overall quality of life. For businesses functioning in contemporary oncology nutrition products, the fall in tolerance to cancer therapy is anticipated to boost the adoption of oncology nutrition. Furthermore, nutritional screening and evaluation are essential for identifying people who are more likely to be malnourished.

Oncology Nutrition Market Trend Analysis

• Creation of elemental formulations and product innovation in terms of non-GMO-based formulas.
• Shift in emphasis from parenteral to enteral nutrition.
• Rising cancer incidence, particularly the rise of patients receiving treatment for malnutrition.
• Rising demand for nutritional feeding in the homecare industry.
• Improving the quality of clinical research on nutritional interventions.

Report Attribute	Details
Oncology Nutrition Market Revenue (2023)	USD 2.07 billion
Market Anticipated Forecast Value (2033)	USD 4.87 billion
Market Projected Growth Rate (2023 to 2033)	8.9%

Global Oncology Nutrition Market Historical Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)

Due to technological developments and extensive research, the cancer nutrition supplements market share is anticipated to expand significantly over the next few years. The demand for oncology nutrition is anticipated to pick up steam throughout the evaluation period, even if the nutritional risk is still mostly beneath the radar.

Attributes	Details
Oncology Nutrition Market Size (2018)	USD 1.33 billion
Market Size (2022)	USD 1.92 billion
Market (CAGR 2018 to 2022)	7.6%

Due to the worldwide increase in cases of malnutrition brought on by tumors, oncology nutrition is still a crucial topic for healthcare professionals. According to several studies, malnutrition screening in cancer treatment could enhance nutritional evaluation and help patients avoid malnutrition.

Key Oncology Nutrition Market Dynamics

Growth Driving Factors in the Oncology Nutrition Market

A significant driver of the cancer nutrition market's growth is projected to be the huge increase in nutritional waste and nutritional risk among cancer patients. Participants in the market landscape are now investigating the possible advantages of utilizing a multidisciplinary strategy, where focused oncology nutrition guidelines are expected to be crucial to improving the standard of cancer care.

The oncology nutrition companies are anticipated to profit from increased research and development activities as well as the launch of cutting-edge products for cancer patients over the forecasted period. The creation of essential formulas and the advent of new markets are also anticipated to boost the cancer nutrition patent landscape and the pace of future expansion.

Due to these factors, the overall market is anticipated to reach USD 3.12 billion by the end of 2027. A few key aspects anticipated to drive the expansion of the market for oncology nutrition research in the upcoming years include:

• Evolving recommendations
• A rise in observational studies
• An increase in clinical trials globally

Due to the considerable increase in the use of nutritional evaluation programs, particularly during cancer cachexia and pre-cachexia, the demand for oncology nutrition is predicted to continue to rise. Over the past ten years, data-gathering methods for varied patients' nutritional status have advanced quickly.

These developments have led to personalized oncology nutrition therapy and are now recognized as the perfect remedy for cancer patients prone to malnutrition.

Factors Influencing the Oncology Nutrition Market Challenges

• As the number of cancer patients keeps increasing, several nations are dealing with significant healthcare difficulties. About 85% of cancer cases globally, in the opinion of many medical professionals, are related to poor nutrition and a sedentary lifestyle.
• The development pace of the oncology nutrition market is likely to be slowed by issues with tube feeling. The poor reimbursement for its usage is likely to hinder the growth of the market for oncology nutrition. Lack of understanding is anticipated to be a new challenge for the oncology nutrition market over the forecast period.
• The insufficient and ambiguous recommendations established by authoritative authorities, as a result of which oncology nutrition stayed at the backseat, is one of the most significant issues that market participants in the oncology nutrition industry have had to cope with over several decades.

Key Trends that may govern the Oncology Nutrition Trends from 2023 to 2033

• The overall market is growing primarily due to the growth in cancer prevalence. Another significant factor influencing the oncology nutrition market's growth rate is the rising cost of healthcare.
• The adoption of oncology nutrition is also anticipated to develop due to improvements in fundamental methods, growing government funding, and rising public and private sector initiatives to increase knowledge of cancer patient nutrition.
• Contrarily, obesity and food are to blame for 35% and 30% of all cancer-related mortality, respectively. Eating many nutritious meals might help cancer patients increase their strength and stamina throughout treatment. Nutrient-rich meals are in more demand because they help stop cancer cells from proliferating.

Segmentation Outlook for the Oncology Nutrition Market

The Gastrointestinal Cancer Segment is Predicted to lead the Market by Cancer Type

The gastrointestinal cancer sector is expected to develop over the research period due to the high incidence of this cancer in the global population.

Attributes	Details
Top Cancer Type	Gastrointestinal Cancer
Market Share in 2023	22.2%

This situation has led to the growth of gastrointestinal cancer nutritional supplements and increased awareness of the importance of nutritional supplement use.

Medical Professionals prefer Enteral Nutrition Parenteral Nutrition Administration

The demand for oncology nutrition is growing because diet provides the ability to fight disease and provides power and endurance against the treatment's side effects.

Attributes	Details
Top Route of Administration Type	Enteral Nutrition
Market Share in 2023	73%

As the number of individuals diagnosed with cancer rises, medical professionals will likely favor the enteral nutrition segment.

Hospitals and Clinics remain the Leading Distribution Channels

The requirement of appropriate medication strategy and prescriptions has resulted in higher sales of all nutrition and supplements market products through hospitals and clinic segments.

Attributes	Details
Top Distribution Channel Type	Hospitals and Clinics
Market Share in 2023	46.8%

So, as per our estimates, this segment is anticipated to remain the leading distribution channel for oncology nutrition products as well through 2033.

Regional Analysis

North America Oncology Nutrition Market Outlook

North America is anticipated to lead the global oncology nutrition market throughout the forecast period. This is due to several important factors, including the increased incidence of cancer and the accessibility of cutting-edge healthcare infrastructure.

The oncology nutrition market in the United States is expected to be worth around USD 412.6 million. According to a statistic from the American Cancer Society, there will likely be 1.9 million new instances of cancer in the United States this year.

Regional Market Comparison	Global Market Share in Percentage
North America	33.4%
Europe	28.8%

Asia Pacific to Witness High Growth Potential in the Oncology Nutrition Market

FMI projects that the Asia Pacific oncology nutrition market is anticipated to expand faster due to the region's rising prevalence of cancer cases. Additionally, several certification programs and awareness sessions are held locally to inform cancer patients and healthcare professionals about the significance of oncology nutrition.

Regional Market Comparison	Global Market Share in Percentage
United States	29.7%
Germany	7.9%
Japan	3.4%

Europe Oncology Nutrition Market to Expand by Active Awareness Programs

• The market in Europe is anticipated to reach a USD 0.55 billion value by the end of the year 2033. Government programs, new product introductions, and partnerships in cancer nutrition supplements all contribute to market expansion. For instance, the 2022 Oncology Nutrition Symposium was held in June 2022 by the Academy of Nutrition and Dietetics.
• The market in the United Kingdom is poised to witness an annual growth rate of 8.3% between 2023 and 2033.

Country wise Insights

• The United States oncology nutrition market holds 29.7% of the global market share. Demand for oncology nutrition is predicted to increase in the United States, fueled by rising spending on various cancer medicines. The United States market is witnessing a dynamic shift spurred by the rising percentage of cancer patients and the convergence of technological breakthroughs.
• By 2026, the second-leading economy in the world, China, is anticipated to have an oncology nutrition market of USD 165 million, indicating a CAGR of 11.9% throughout the research. China is projected to keep being one of the countries with the quickest rate of growth in the Asia Pacific oncology nutrition market.
• Other significant geographic oncology nutrition markets include Japan and Canada, with growth rates of 7.4% and 7.1%, respectively, predicted for the projected period.
• Latin America is anticipated to expand at a 7.6% CAGR throughout the study period, while the Asia Pacific oncology nutrition market is anticipated to reach USD 19.2 million, driven by countries like Australia, India, and South Korea.

Regional Markets	CAGR (2023 to 2033)
United Kingdom	8.3%
China	11.9%
India	9.4%
Australia	9.6%

Startup Ecosystem

With certain leading pharmaceutical corporations, startups in the oncology nutrition sector are working hard in this area. Clinical studies now include parenteral oncology feeding. Oncology nutrition is projected to become more popular as cancer incidence and the demand for tailored medication and nutrition rise.

In the market for cancer nutrition, collaboration with nutritionists and oncology research institutes is also anticipated to present considerable prospects for companies. For instance, the American biotechnology giant Celgene Corporation teamed up with Savor Health, a provider of specialized nutritional advice to cancer patients.

Competitive Landscape of the Oncology Nutrition Market

New product launches and continuous technological innovations are the key strategies adopted by prominent players in the oncology nutrition market. The healthcare systems organizations are changing due to new research and increased public knowledge of the advantages of oncology nutrition. Clinical nutritionists and oncologists are working more closely to improve oncology nutrition and treatment within the oncology nutrition sector.

The presence of competitors, new product debuts, and partnerships related to the industry under consideration all contribute to the market's growth. According to the report, Esperer launched its nutrition development center in Hyderabad in 2020. The facility in Hyderabad is expected to house a variety of cohesive capabilities, such as investigative workrooms and product development sub-centers, with a dedicated laboratory for analyzing sensory components, packing, and taste.

The leading firms worldwide for oncology nutrition are focused on obtaining regulatory clearances, developing cutting-edge goods, introducing new products, and partnering with and acquiring other businesses. The global market for oncology nutrition is projected to expand due to these leading players' tactics. The following are a few expansion methods used by companies in the oncology nutrition market:

• To increase its presence in medical nutrition, Nestle acquired the Allergan business in January 2020.
• Smartfish AS and B. Braun worked together to introduce Remune, a medicinal nutrition solution, in September 2019. In 2019 and 2020, B. Braun introduced Remune in over 20 nations. Several other markets in Europe, Asia, and South America followed.
• Ina, the intelligent nutrition helper, was introduced by CancerCare in collaboration with Savor Health in 2019. The Ina offers tailored, evidence-based nutrition counseling to help cancer patients eat well and stay fed during treatment.
• A three-chamber bag with a unique protein-to-energy ratio called mofKabiven additional Nitrogen was introduced by Fresenius Kabi AG in 2018 in Europe.
• The SmartPN tool was introduced in October 2018 by Baxter International Inc. and the American Society for Parenteral and Enteral Nutrition (ASPEN) to reduce clinical malnutrition.

Key Players in the Oncology Nutrition Market

• FMC Corporation
• Danone India
• Abbott
• Aceto
• B. Braun Melsungen AG
• Baxter
• Fresenius Kabi AG
• Global Health Products, Inc.
• Hormel Foods Corporation
• Mead Johnson & Company, LLC
• Meiji Holdings Co., Ltd
• Nestlé S.A.
• BioSig Technologies, Inc.
• Auris Health, Inc.

Scope of the Report

Attribute	Details
Growth Rate	CAGR of 8.9% from 2023 to 2033
Base Year of Estimation	2022
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in USD million and F-CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered	By Cancer Type, By End Use, By Region
Regions Covered	North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, Italy, France, United Kingdom, Spain, Russia, China, Japan, GCC Countries, Australia
Key Companies Profiled	FMC Corporation; Danone India; Abbott; Aceto; B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Mead Johnson & Company, LLC; Meiji Holdings Co., Ltd; Nestlé S.A.; BioSig Technologies, Inc.; Auris Health, Inc.

Key Segments

By Cancer Type:

• Head & Neck Cancer
• Stomach & Gastrointestinal Cancers
• Blood Cancer
• Breast Cancer
• Lung Cancer
• Other cancers

By End Use:

• Hospitals & Clinics
• Home Care
• Others

By Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific
• Latin America
• The Middle East and Africa

Frequently Asked Questions

What is the Oncology Nutrition Market Size in 2023?

The overall market is estimated to be around USD 2.07 billion in 2023.

Who are the Market Leaders in Oncology Nutrition?

FMC, Danone, and Abbott are some of the leading market players.

What is Oncology Nutrition?

Proper management of diet intake of patients undergoing cancer treatment.

How Big is the Clinical Nutrition Market?

The hospitals and clinical market segment contributed 46.8% of revenue in 2022.

What are the Trends in the Oncology Nutrition Industry?

Collaborations with nutritionists and oncology research institutes are driving the market.